Balance Sheet Vaxcyte, Inc.

Equities

PCVX

US92243G1085

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 14/09/2024 am IST			5-day change	1st Jan Change
116.00 ^USD	+1.64%		+3.96%	+84.71%

10/09	Analyst recommendations: Apple, Oracle, Progressive, Dollar Tree...
10/09	Mizuho Boosts Price Target on Vaxcyte to $163 From $113, Maintains Outperform Rating	MT

0c70e7fb994e19.zS-kx8eDI6YMzcXHpbL6Zha5ymAqbWJ5KsGho_7iTJ4.j3zlk77xQp50roqPwtG9KW_B51hLOCAIYZ7g1byYDfy0buaxtskSwj2jlA

Published financial data: VAXCYTE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Cost of Goods Sold, Total	-	-	-	23M	75M
Gross Profit	-	-	-	-23M	-75M
Selling General & Admin Expenses, Total	8.55M	16.02M	25.26M	39.81M	60.7M
R&D Expenses	45.61M	73.56M	78.41M	169M	332M
Other Operating Expenses, Total	54.15M	89.58M	104M	209M	393M
Operating Income	-54.15M	-89.58M	-104M	-232M	-468M
Interest Expense, Total	-40K	-7K	-7K	-2K	-
Interest And Investment Income	632K	244K	344K	8.36M	62.91M
Net Interest Expenses	592K	237K	337K	8.35M	62.91M
Currency Exchange Gains (Loss)	-135K	-2.35M	1.67M	-1.47M	-1.9M
Other Non Operating Income (Expenses)	237K	2.48M	1.58M	1.93M	4.76M
EBT, Excl. Unusual Items	-53.46M	-89.22M	-100M	-223M	-402M
Gain (Loss) On Sale Of Investments	-	-	2K	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-44K	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	3.18M	-	-	-	-
EBT, Incl. Unusual Items	-50.27M	-89.22M	-100M	-223M	-402M
Earnings From Continuing Operations	-50.27M	-89.22M	-100M	-223M	-402M
Net Income to Company	-50.27M	-89.22M	-100M	-223M	-402M
Net Income - (IS)	-50.27M	-89.22M	-100M	-223M	-402M
Net Income to Common Incl Extra Items	-50.27M	-89.22M	-100M	-223M	-402M
Net Income to Common Excl. Extra Items	-50.27M	-89.22M	-100M	-223M	-402M
Per Share Items
Net EPS - Basic	-13.25	-3.02	-1.93	-3.44	-4.14
Basic EPS - Continuing Operations	-13.25	-3.02	-1.93	-3.44	-4.14
Basic Weighted Average Shares Outstanding	3.8M	29.55M	51.92M	64.88M	97.16M
Net EPS - Diluted	-13.25	-3.02	-1.93	-3.44	-4.14
Diluted EPS - Continuing Operations	-13.25	-3.02	-1.93	-3.44	-4.14
Diluted Weighted Average Shares Outstanding	3.8M	29.55M	51.92M	64.88M	97.16M
Normalized Basic EPS	-8.8	-1.89	-1.2	-2.15	-2.59
Normalized Diluted EPS	-8.8	-1.89	-1.2	-2.15	-2.59
Supplemental Items
EBITDA	-52.92M	-88.18M	-102M	-230M	-465M
EBITA	-54.15M	-89.58M	-104M	-232M	-468M
EBIT	-54.15M	-89.58M	-104M	-232M	-468M
EBITDAR	-52.32M	-87.48M	-98.67M	-222M	-456M
Normalized Net Income	-33.41M	-55.76M	-62.55M	-140M	-251M
Interest on Long-Term Debt	40K	7K	7K	2K	-
Supplemental Operating Expense Items
General and Administrative Expenses	8.55M	16.02M	25.26M	39.81M	60.7M
Research And Development Expense From Footnotes	45.61M	73.56M	78.41M	169M	332M
Net Rental Expense, Total	600K	700K	3.2M	7.9M	8.5M
Imputed Operating Lease Interest Expense	101K	-	-	7.27K	-
Imputed Operating Lease Depreciation	499K	-	-	7.89M	-
Stock-Based Comp., R&D Exp. (Total)	368K	1.86M	3.95M	9.9M	23.28M
Stock-Based Comp., G&A Exp. (Total)	817K	3.57M	6.78M	13.75M	25.48M
Total Stock-Based Compensation	1.18M	5.43M	10.73M	23.65M	48.76M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	58.98M	386M	68.98M	835M	397M
Short Term Investments	-	-	177M	96.72M	683M
Total Cash And Short Term Investments	58.98M	386M	246M	931M	1.08B
Other Receivables	-	300K	1.2M	1M	3.61M
Total Receivables	-	300K	1.2M	1M	3.61M
Prepaid Expenses	2.75M	2.5M	9.18M	10.18M	6.16M
Other Current Assets, Total	-	-	-	-	5.96M
Total Current Assets	61.72M	389M	256M	943M	1.1B
Gross Property Plant And Equipment	6.37M	7.37M	41.12M	37.76M	120M
Accumulated Depreciation	-2.98M	-4.1M	-5.2M	-6.12M	-9.27M
Net Property Plant And Equipment	3.39M	3.27M	35.91M	31.65M	111M
Long-term Investments	-	-	27.12M	26.55M	163M
Deferred Charges Long-Term	-	100K	500K	-	-
Other Long-Term Assets, Total	584K	450K	4.46M	5.43M	38.66M
Total Assets	65.7M	393M	324M	1.01B	1.41B
Liabilities
Accounts Payable, Total	3.38M	29.78M	6.76M	9.8M	14.59M
Accrued Expenses, Total	7.5M	17.06M	16.68M	24.82M	124M
Current Portion of Leases	161K	-	5.28M	5.91M	7.11M
Other Current Liabilities	19K	14K	-	-	-
Total Current Liabilities	11.05M	46.86M	28.72M	40.52M	145M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	-	-	11.51M	12.03M	22.11M
Other Non Current Liabilities	259K	122K	96K	9K	-
Total Liabilities	11.31M	46.98M	40.32M	52.56M	167M
Preferred Stock Convertible	160M	-	-	-	-
Preferred Stock - Others	450K	-	-	-	-
Total Preferred Equity	161M	-	-	-	-
Common Stock, Total	7K	54K	56K	82K	98K
Additional Paid In Capital	2.97M	544M	583M	1.48B	2.16B
Retained Earnings	-109M	-199M	-299M	-522M	-924M
Comprehensive Income and Other	-	-	-241K	-361K	179K
Total Common Equity	-106M	346M	284M	954M	1.24B
Total Equity	54.39M	346M	284M	954M	1.24B
Total Liabilities And Equity	65.7M	393M	324M	1.01B	1.41B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.06M	51.33M	56.31M	80.03M	108M
ECS Total Common Shares Outstanding	4.06M	51.07M	53.03M	79.47M	95.36M
Book Value / Share	-26.2	6.77	5.36	12	13.01
Tangible Book Value	-106M	346M	284M	954M	1.24B
Tangible Book Value Per Share	-26.2	6.77	5.36	12	13.01
Total Debt	161K	0	16.78M	17.94M	29.22M
Net Debt	-58.82M	-386M	-229M	-913M	-1.05B
Debt Equivalent Oper. Leases	4.8M	5.6M	25.6M	63.2M	68M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	3.8M	5.25M	11.5M	15.12M	35.62M
Full Time Employees	-	58	89	158	254
Assets under Capital Lease - Gross	686K	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-50.27M	-89.22M	-100M	-223M	-402M
Depreciation & Amortization - CF	1.23M	1.4M	3.46M	9.2M	10.17M
Depreciation & Amortization, Total	1.23M	1.4M	3.46M	9.2M	10.17M
(Gain) Loss From Sale Of Asset	1K	34K	97K	44K	-
(Gain) Loss on Sale of Investments - (CF)	-	-	1.41M	-947K	-34.78M
Asset Writedown & Restructuring Costs	-	267K	-	213K	-
Stock-Based Compensation (CF)	1.18M	5.43M	10.73M	23.65M	48.76M
Other Operating Activities, Total	-3.2M	179K	-	8M	-
Change In Accounts Payable	868K	26.1M	-12.47M	2.9M	11.22M
Change in Other Net Operating Assets	3.04M	9.17M	-24.54M	9.84M	70.1M
Cash from Operations	-47.14M	-46.63M	-121M	-171M	-297M
Capital Expenditure	-1.2M	-1.16M	-6.56M	-5.85M	-67.88M
Sale of Property, Plant, and Equipment	-	50K	26K	7K	-
Investment in Marketable and Equity Securities, Total	-	-	-206M	80.43M	-705M
Cash from Investing	-1.2M	-1.1M	-212M	74.58M	-773M
Long-Term Debt Repaid, Total	-278K	-61K	-	-	-
Total Debt Repaid	-278K	-61K	-	-	-
Issuance of Common Stock	442K	268M	17.8M	862M	644M
Issuance of Preferred Stock	42.5M	110M	-	-	-
Other Financing Activities, Total	-1.1M	-3.49M	-	-861K	-3.88M
Cash from Financing	41.57M	375M	17.8M	862M	640M
Foreign Exchange Rate Adjustments	-341K	87K	-439K	137K	-6.69M
Net Change in Cash	-7.11M	327M	-316M	766M	-437M
Supplemental Items
Cash Interest Paid	40K	7K	7K	2K	-
Levered Free Cash Flow	-30.34M	-14.4M	-88.16M	-108M	-202M
Unlevered Free Cash Flow	-30.32M	-14.39M	-88.16M	-108M	-202M
Change In Net Working Capital	-2.31M	-35.91M	31M	-10.37M	-99.06M
Net Debt Issued / Repaid	-278K	-61K	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-49.59	-24.42	-18.07	-21.82	-24.23
Return on Total Capital	-57.01	-27.97	-20.04	-22.82	-26.1
Return On Equity %	-87.49	-44.58	-31.78	-36.11	-36.67
Return on Common Equity	61.27	-74.51	-31.78	-36.11	-36.67
Short Term Liquidity
Current Ratio	5.58	8.3	8.93	23.26	7.54
Quick Ratio	5.34	8.25	8.61	23.01	7.46
Operating Cash Flow to Current Liabilities	-4.27	-1	-4.23	-4.21	-2.04
Average Days Payable Outstanding	-	-	-	131.37	59.33
Long Term Solvency
Total Debt/Equity	0.3	-	5.91	1.88	2.36
Total Debt / Total Capital	0.3	-	5.58	1.85	2.3
LT Debt/Equity	-	-	4.05	1.26	1.78
Long-Term Debt / Total Capital	-	-	3.83	1.24	1.74
Total Liabilities / Total Assets	17.22	11.96	12.43	5.22	11.89
EBIT / Interest Expense	-1.35K	-12.8K	-14.81K	-116K	-
EBITDA / Interest Expense	-1.32K	-12.6K	-14.1K	-111K	-
(EBITDA - Capex) / Interest Expense	-1.35K	-12.76K	-15.03K	-114K	-
Total Debt / EBITDA	-0	-	-0.17	-0.08	-0.06
Net Debt / EBITDA	1.11	4.38	2.32	4.12	2.3
Total Debt / (EBITDA - Capex)	-0	-	-0.16	-0.08	-0.06
Net Debt / (EBITDA - Capex)	1.09	4.32	2.18	4.01	2
Growth Over Prior Year
Gross Profit, 1 Yr. Growth %	-	-	-	-	226.16
EBITDA, 1 Yr. Growth %	53.41	66.62	15.53	125.46	102.41
EBITA, 1 Yr. Growth %	52.4	65.42	15.73	124.03	101.52
EBIT, 1 Yr. Growth %	52.4	65.42	15.73	124.03	101.52
Earnings From Cont. Operations, 1 Yr. Growth %	70.51	77.46	12.17	123.31	80
Net Income, 1 Yr. Growth %	70.51	77.46	12.17	123.31	80
Normalized Net Income, 1 Yr. Growth %	54.22	66.89	12.17	123.26	80.03
Diluted EPS Before Extra, 1 Yr. Growth %	63.58	-77.21	-36.17	78.72	20.19
Net Property, Plant and Equip., 1 Yr. Growth %	-0.59	-3.51	997.56	-11.87	249.54
Total Assets, 1 Yr. Growth %	-7.21	497.93	-17.44	210.23	39.93
Tangible Book Value, 1 Yr. Growth %	84.27	-425.12	-17.88	235.76	30.08
Common Equity, 1 Yr. Growth %	84.27	-425.12	-17.88	235.76	30.08
Cash From Operations, 1 Yr. Growth %	54.75	-1.1	160.34	40.53	73.97
Capital Expenditures, 1 Yr. Growth %	-32.64	-3.35	467.53	-10.79	1.06K
Levered Free Cash Flow, 1 Yr. Growth %	50.39	-52.56	512.43	22.26	87.78
Unlevered Free Cash Flow, 1 Yr. Growth %	50.62	-52.53	512.58	22.27	87.78
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	75.37	59.88	38.74	61.39	113.62
EBITA, 2 Yr. CAGR %	74.26	58.78	38.36	61.02	112.48
EBIT, 2 Yr. CAGR %	74.26	58.78	38.36	61.02	112.48
Earnings From Cont. Operations, 2 Yr. CAGR %	70.78	73.95	41.09	58.27	100.49
Net Income, 2 Yr. CAGR %	70.78	73.95	41.09	58.27	100.49
Normalized Net Income, 2 Yr. CAGR %	73.9	60.43	36.82	58.26	100.49
Diluted EPS Before Extra, 2 Yr. CAGR %	65.53	-39.03	-61.86	6.81	46.56
Net Property, Plant and Equip., 2 Yr. CAGR %	6.82	-2.06	225.43	211	75.51
Total Assets, 2 Yr. CAGR %	28.75	135.55	122.19	60.04	108.35
Tangible Book Value, 2 Yr. CAGR %	91.09	144.76	63.4	66.05	108.99
Common Equity, 2 Yr. CAGR %	91.09	144.76	63.4	66.05	108.99
Cash From Operations, 2 Yr. CAGR %	77.5	23.71	60.46	91.28	56.36
Capital Expenditures, 2 Yr. CAGR %	-1.11	-19.31	134.21	125.02	221.79
Levered Free Cash Flow, 2 Yr. CAGR %	-	-15.53	70.46	173.64	51.52
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-15.45	70.52	173.68	51.53
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	72.4	43.47	63.12	74.05
EBITA, 3 Yr. CAGR %	-	71.26	42.89	62.47	73.52
EBIT, 3 Yr. CAGR %	-	71.26	42.89	62.47	73.52
Earnings From Cont. Operations, 3 Yr. CAGR %	-	72.98	50.28	64.43	65.2
Net Income, 3 Yr. CAGR %	-	72.98	50.28	64.43	65.2
Normalized Net Income, 3 Yr. CAGR %	-	71.53	42.39	61.08	65.2
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-14.52	-38.09	-36.17	11.1
Net Property, Plant and Equip., 3 Yr. CAGR %	-	3.26	119.17	110.54	223.35
Total Assets, 3 Yr. CAGR %	-	114.81	66.08	148.34	53.04
Tangible Book Value, 3 Yr. CAGR %	-	128.13	70.08	107.74	53.07
Common Equity, 3 Yr. CAGR %	-	128.13	70.08	107.74	53.07
Cash From Operations, 3 Yr. CAGR %	-	46.06	58.54	53.52	85.33
Capital Expenditures, 3 Yr. CAGR %	-	-1.86	54.6	69.78	288.79
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	63.49	52.58	141.36
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	63.61	52.62	141.39
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	67.91	68.23
EBITA, 5 Yr. CAGR %	-	-	-	67.09	67.47
EBIT, 5 Yr. CAGR %	-	-	-	67.09	67.47
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	66.94	68.65
Net Income, 5 Yr. CAGR %	-	-	-	66.94	68.65
Normalized Net Income, 5 Yr. CAGR %	-	-	-	66.09	63.28
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-6.56	-12.61
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	60.49	100.54
Total Assets, 5 Yr. CAGR %	-	-	-	90.95	81.85
Tangible Book Value, 5 Yr. CAGR %	-	-	-	100.91	84.69
Common Equity, 5 Yr. CAGR %	-	-	-	100.91	84.69
Cash From Operations, 5 Yr. CAGR %	-	-	-	62.7	57.66
Capital Expenditures, 5 Yr. CAGR %	-	-	-	36.77	107.28
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	58.59
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	58.66